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The budded form of Autographa californica M nucleopolyhedrovirus enters permissive cells via adsorptive endocytosis.
Shortly after nucleocapsid penetration into the cytoplasm, thick actin cables form, which frequently project toward the
nucleus. These actin cables are transient structures, formed in association with viral nucleocapsids prior to viral gene
expression and concomitant with nucleocapsid transport to the nucleus. In this paper we report that nucleocapsids are
capable of nucleating actin polymerization in vitro in a concentration-dependent manner. Two viral-encoded capsid proteins,
p39 and p78/83, were found to bind actin directly and therefore could be involved in the observed acceleration of actin
polymerization. When nucleocapsids were added to actin in the presence of cytochalasin D, actin polymerization was
reduced to levels below those obtained with actin and cytochalasin D alone, suggesting that the nucleocapsids bound to the
pointed ends of actin filaments. Finally, treatment of infected cells with the myosin inhibitor 2,3-butanedione monoxime
delayed nucleocapsid transport to the nucleus. We postulate that upon entering the cytoplasm, AcMNPV nucleocapsids
induce the polymerization of actin cables, which, in conjunction with a myosin-like motor, facilitate their transport to and/or
into the nucleus. © 1998 Academic Press
INTRODUCTION
Viruses are obligate intracellular parasites. As such,
they must manipulate and exploit their host cells to their
own advantage, recruiting whatever host factors they
need. Cytoskeletal proteins have served in this regard as
viral replication and/or transcription factors (Moyer et al.,
1990; De et al., 1991), and virus localization in the cyto-
plasm has been correlated with interaction with the cy-
toskeleton (Bowden et al., 1987; Pearce-Pratt et al., 1994;
Strauss, 1996; Cudmore et al., 1997). Sodeik et al. (1997)
recently provided compelling evidence that herpes virus
simplex 1 parental nucleocapsids use microtubules for
transport to the nucleus, and Cudmore et al. (1995) dem-
onstrated that vaccinia virus progeny induce and use the
vectoral polymerization of actin to bud from cells. Al-
though these and other viral interactions with the cy-
toskeleton are well documented, relatively few specific
viral proteins have been shown to bind directly to cy-
toskeletal proteins, and, where it has been shown, the
functional significance of these interactions has not
been well understood.
Autographa californica M nucleopolyhedrovirus (AcM-
NPV), the type species of genus Nucleopolyhedrovirus,
family Baculoviridae, is an enveloped, double-stranded
DNA virus that infects lepidopteran larvae. There are two
forms of AcMNPV; one which transmits infection from
insect to insect, while the other form, budded virus (BV),
spreads infection from cell to cell within an infected
insect. BV enters cells by adsorptive endocytosis. Re-
lease of BV nucleocapsids from endosomes into the
cytoplasm induces the formation of thick actin cables
(Charlton and Volkman, 1993). These cables are detected
only transiently from 1-4 hours post infection (hpi), during
which time the entire viral nucleocapsid travels to and
enters the nucleus (Granados, 1980). During this period,
viral nucleocapsids are often co-localized with one end
of an actin cable while the other end is oriented away
from the virion (Charlton and Volkman, 1993). These
observations led to the speculation that cable formation
could be involved in transport of nucleocapsids to the
nucleus. In this paper we report on the capability of
AcMNPV nucleocapsids to induce actin polymerization
in vitro, and present evidence that these actin cables
may be involved in the transport of viral nucleocapsids to
and/or into the nucleus.
RESULTS
Visualization of virus-induced actin polymerization
To test whether BV nucleocapsids could induce actin
polymerization, BV and sBV were mixed with G-actin
under polymerizing conditions and examined by fluores-
cence microscopy. A dramatic increase in the amount of
F-actin was observed in the presence of sBV compared
to only a slight increase in F-actin in the presence of
unsolubilized BV (compare Figs 1F and 1E). Results sim-
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FIG. 1. Visualization of sBV-induced in vitro polymerization of actin by fluorescence microscopy. Unlabeled G-actin (5 mM) in G buffer was mixed
with 1 mg of BV or sBV; subsequently 2 mM MgCl2, 0.5 mM ATP was added to initiate actin polymerization (final volume, 100 ml). The entire mixture
was spread onto a poly-L-lysine coated glass coverslip and allowed to settle for 30 min, after which F-actin was labeled with 1.5 mM rhodamine-
phalloidin and DNA in the nucleocapsid was labeled with DAPI. Nucleocapsid-associated actin was detected by incubating BV with rhodamine-
168 LANIER AND VOLKMAN
ilar to those with sBV were obtained using purified nu-
cleocapsids (data not shown), suggesting that an actin-
polymerizing activity was associated with nucleocap-
sids. In the absence of exogenous actin, punctate
rhodamine-phalloidin labeling was detected in associa-
tion with the DAPI-stained viral nucleocapsids of both BV
and sBV (Figs 1B, 1C and 1D), even when labeling was
performed in the absence of additional MgCl2 (data not
shown). The labeling of this actin with phalloidin in the
absence of MgCl2 could indicate that the nucleocapsid-
associated actin was filamentous rather than globular.
Alternatively, the actin could have been globular origi-
nally, but was induced to polymerize by the high concen-
tration of phalloidin label (Sampath and Pollard, 1991).
When actin (alone) was tested, a few, relatively long actin
filaments were observed (Fig. 1A). Formation of these
filaments may have been due, in part, to the nucleating
effect of the positively charged poly-L-lysine surface (Lin
et al., 1980).
Actin is tightly associated with BV capsids
To determine which BV components were associated
with actin, we analyzed nucleocapsids, envelopes, cap-
sids and DNA cores by western blot (Fig. 2). Not surpris-
ingly, much of the actin partitioned with the envelope
fraction, suggesting that it was non-specifically trapped
(Fig. 2B; Damsky et al., 1977). The remaining actin, how-
FIG. 2. BV fractionation. (A) Diagram of fractionation procedure; BV (100 mg) was treated with 1% NP40 and centrifuged to produce NC and ENV
fractions. For some experiments, nucleocapsids prepared from 100 mg of BV were treated with 1M NaCl at 37°C and centrifuged to produce CAP and
DNA COR fractions. (B) Analysis of viral fractions. All fractions were electrophoresed on a 15% SDS-PAGE gel and transferred to nitrocellulose. The
viral proteins p78/83, gp64, and p39, and cellular actin were identified by immunoblot followed by DAB staining (p78/83) or chemiluminescence
detection (gp64, actin, p39). The p6.9 protein was visualized by Coomassie staining of the gel before transfer.
phalloidin (B), and sBV with rhodamine-phalloidin and DAPI (C, D). The effect of sBV on actin polymerization was evident when the rhodamine-
phalloidin labeling of actin incubated alone (A) was compared with that of actin incubated with sBV (F), or with BV (E).
FIG. 8. BDM induced aggregation of viral nucleocapsids. Cells were infected with AcMNPV-hsp70/lacZ at an moi of 100 in the absence or presence
of 20 mM BDM. At 5 hpi, cells were fixed and processed for immunofluorescence. Viral nucleocapsids (green) were identified using a primary antibody
to p39 followed by a fluorescein-conjugated secondary antibody. Cell nuclei (blue) were stained with DAPI. Images were captured at a mid-nuclear
plane of focus. (A) Cells infected in the absence of BDM. Arrows point to individual nucleocapsids, some of which appear to be in the nucleus. (B)
Cells infected in the presence of BDM. Arrows point to aggregates of nucleocapsids which appear to be outside the nucleus. Bar, 5 mm.
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ever, was associated with the nucleocapsid, and most of
that subsequently with the capsid even after prolonged
incubation in 1M NaCl and DNAse I at 37° (i.e., the
capsid prep). Only a small amount of actin appeared in
the COR fraction after the NaCl/DNAase I treatment.
Actin, therefore, appeared to be tightly and specifically
attached to the capsid. Surprisingly, this actin remained
bound to the capsid even after extensive dialysis with
EDTA (data not shown), a treatment that has been shown
to remove actin from other actin-binding proteins (Hitch-
cock, 1980; Oosawa and Maruyama, 1987; Shariff and
Luna, 1990; Carpen et al., 1992).
Nucleocapsids and capsids accelerate actin
polymerization
Quantification of fluorescence emission by pyrene-con-
jugated actin is a sensitive, non-shearing method for mea-
suring actin polymerization without affecting the kinetics of
polymerization (Cooper et al., 1983). Using this technique,
we found that sBV increased the rate of actin polymeriza-
tion in a concentration-dependent manner (Fig. 3A, B), while
NP40, alone, had no effect (data not shown). In addition,
sBV reduced, but did not eliminate, the initial lag phase in
actin polymerization (Fig. 3A, inset), and pre-incubation of
G-actin with 250 mM MgCl2 at 0°C for 5 minutes failed to
eliminate the effect of sBV on actin polymerization (data not
shown). Together these results suggested that sBV nucle-
ated actin polymerization rather than potentiated the initial,
salt-induced conformational change in actin monomers (ac-
tivation). The sBV-induced increase in the rate of polymer-
ization was linear over the range of sBV concentrations
tested (Fig. 3B).
To determine which of the viral components was ac-
tive in nucleating actin polymerization, fractionated BV
(Fig. 2) was used in pyrene-actin polymerization experi-
ments. Viral nucleocapsids, but not envelopes, retained
the ability to accelerate actin polymerization (Fig. 4A).
The fact that the envelope fraction contained more actin
than the nucleocapsid fraction (Fig. 2), but did not accel-
erate actin polymerization (Fig. 4A), suggested that the
actin, by itself, was not the actin-nucleating activity. The
observed acceleration of actin polymerization by non-
solubilized BV was similar to the slight increase in F-
actin detected by direct visualization (Fig. 1E), and most
likely was due to rupturing of the loose viral envelopes
(i.e. partial ‘‘solubilization’’) during BV preparation, as in-
creased trituration or rough handling of the concentrated
BV increased the ability of BV to accelerate polymeriza-
tion (data not shown). Finally, purified capsids retained
some ability to accelerate actin polymerization (Fig. 4B),
but quantification of polymerization was complicated by
the fact that capsids, and to some extent nucleocapsids,
were extremely difficult to resuspend; the reduced poly-
merization activity associated with capsids, therefore,
may have reflected the functional loss of material due to
aggregation. Subsequent studies of the actin polymeriz-
ing activity were done with sBV in order to avoid this
technical difficulty.
Nucleocapsids bind the pointed end of actin filaments
The initial lag phase in actin polymerization kinetics
represents the formation of actin trimers, and is the rate
limiting step (Wegner and Engel, 1975). Some proteins,
termed actin nucleators, bind actin, reduce the lag
phase, and often remain bound to one end of the actin
filament (Pollard and Cooper, 1986). Because sBV re-
duced the initial lag phase of actin polymerization (Fig.
3A, inset), we investigated the possibility that sBV bound
to one end of the filament by testing the effect of CD on
sBV-induced nucleation and acceleration of actin poly-
merization. CD binds and caps the barbed end of actin
filaments, thereby preventing polymerization at the fast
growing end of the filament; residual actin polymeriza-
FIG. 3. Pyrene actin polymerization in the presence of sBV. G-actin (5
mM, 20% pyrene-labeled) in G buffer was mixed with the indicated amount
of sBV, then polymerization was initiated by addition of 2 mM MgCl2, 0.5
mM ATP (final volume 100 ml), and fluorescence emission at 407 nm was
recorded continuously over time. Actin polymerization is given in arbitrary
units (A.U.) of fluorescence. (A) Polymerization of actin alone or with the
indicated amount of sBV. Inset, enlargement of the curves from 0-10 min.
(B) Change in polymerization taken from the linear phase of each curve in
(A) plotted versus the concentration of sBV.
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tion in the presence of CD alone represents polymeriza-
tion from the pointed, slow-growing end of the filament
(Cooper, 1987). In the presence of sBV and CD, actin
polymerization was reduced below levels seen in the
presence of CD alone, suggesting that some component
of the nucleocapsid was binding at the pointed end of
the filament so that in the presence of both sBV and CD,
neither end of the filament was free to elongate (Fig. 5,
compare 9 1 sBV 1 CD9 with 9 1 CD9).
Identification of viral actin-binding proteins by actin
overlay assay
The results of the above experiments suggested that
at least one nucleocapsid-associated protein specifically
bound actin. Five proteins have been identified as AcM-
NPV nucleocapsid-associated proteins; their estimated
masses are, 78/83 kDa (Vialard and Richardson, 1993),
80 kDa (Muller et al., 1990; Lu and Carstens, 1992), 39
kDa (Thiem and Miller, 1989), 24 kDa (Wolgamot et al.,
1993), and 6.9 kDa (Wilson et al., 1987). To identify viral
actin-binding proteins, we performed actin overlay as-
says on fractionated and whole BV preparations. Similar
assays were conducted on extracts of bacteria that ex-
pressed p78 to distinguish it from the 80 kDa nucleocap-
sid protein. The actin overlay experiments revealed that
two capsid proteins, p39 and p78/83, bound strongly and
specifically to actin (Fig. 6A), while no specific binding by
envelope proteins was detected. Subsequent immuno-
staining of the overlay blots (Fig. 6B) confirmed these
results. Other faint bands varied from experiment to ex-
periment and therefore most likely represented non-spe-
cific binding (Fig. 6A, B). The finding that bacterially
expressed p78 (the un-phosphorylated form of p83)
bound actin not only confirmed its identity as the actin-
binding protein, but further indicated that phosphoryla-
tion was not necessary for its actin-binding activity (Fig
6A). Whether phosphorylation actually inhibits actin bind-
ing by p83 remains to be determined.
The results of the actin overlay experiments indicated
that p39 bound to both G-actin and F-actin, although
binding to G-actin sometimes appeared stronger (Fig.
6A, C). In contrast, p78/83 bound only to F-actin (Fig. 6A).
The fact that 125I-labeled G-actin bound to p39 but not to
FIG. 4. Pyrene actin polymerization in the presence of BV fractions. G-actin (5 mM, 20% pyrene-labeled) in G buffer was mixed with the indicated
BV fraction, then polymerization was initiated by addition of 2 mM MgCl2, 0.5 mM ATP (final volume 100 ml), and fluorescence emission at 407 nm
was recorded continuously over time. Actin polymerization is given in arbitrary units (A.U.) of fluorescence. BV fractions were prepared from 100 mg
of BV as discussed (see Materials and Methods and Fig. 2). (A) Polymerization of actin alone or with intact BV (1BV), solubilized BV (1sBV),
nucleocapsids (1NC) or viral envelope fraction (1ENV). (B) Polymerization of actin alone or with nucleocapsids (1NC), or capsids (1CAP).
FIG. 5. Pyrene actin polymerization in the presence of CD and sBV.
G-actin (5 mM, 20% pyrene-labeled) in G buffer was mixed with 100 mg
of solubilized budded virus (1sBV), or with 0.5 mM CD with or without
100 mg sBV (1CD; 1CD 1 sBV), then polymerization was initiated by
addition of 2 mM MgCl2, 0.5 mM ATP and fluorescence emission at 407
nm was recorded continuously over time. Actin polymerization is given
in arbitrary units (A.U.) of fluorescence.
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p78/83 implied that the binding was specific. The spec-
ificity of the observed actin-binding activities was tested
further by competition of 125I-actin binding with 100 fold
excess (1 mg/ml) of unlabeled actin. Because 1 mg/ml
G-actin will polymerize when incubated in overlay block,
the G-actin competition is referred to as G3F competi-
tion. Competition with un-labeled G3F-actin reduced
binding of 125I-labeled G-actin to p39 and competition
with un-labeled F-actin reduced binding of 125I-labeled
F-actin to p78/83 (Fig. 6C). In contrast, p39 binding to
125I-labeled F-actin was not detectably reduced in the
presence of the un-labeled F-actin. While this could
mean that F-actin binding to p39 was non-specific, the
lack of detectable competition could be attributable to
the stoichiometry involved; there are estimated to be
hundreds of molecules of p39 in each nucleocapsid
(Burley et al., 1982), while, by comparison, p78/83 is a
minor structural protein. The 100 fold excess of unla-
beled F-actin may have been sufficient to saturate actin
binding by p78/83, therefore, but insufficient to saturate
and compete for binding by all the p39 molecules in 35
mg of BV (Volkman et al., 1976). Taken together, these
results indicated that p39 bound specifically to G-actin
(and perhaps, F-actin), and p78/83 bound specifically to
F-actin.
Nuclear transport is inhibited by BDM
The data presented above indicated that AcMNPV BV
nucleocapsids were able to nucleate actin polymeriza-
tion and bind the pointed end of actin filaments. Such an
orientation would be correct for myosin-facilitated move-
ment of nucleocapsids through the cytoplasm. To test
whether myosin might be involved in nucleocapsid trans-
port to the nucleus, we infected cells with AcMNPV-
hsp70/lacZ in the presence or absence of the myosin
inhibitor BDM and compared numbers of cells signaling
at various times post infection. BDM is believed to inhibit
myosin function by blocking the release of phosphate
after ATP hydrolysis (Herrmann et al., 1992), but does not
inhibit actin polymerization (Carlier, 1990; Cramer et al.,
1994). In the absence of BDM, LacZ expression was first
detected at 2 hpi and reached high levels by 4 hpi (Fig.
7A). Treatment with BDM (added with the warm medium)
delayed the first LacZ signaling until 4 hpi and led to a
greater than 100 fold reduction in the number of infected
cells detected at 6 hpi (Fig. 7A).
It has been reported that a type I myosin is involved in
receptor-mediated endocytosis (Geli and Reizman, 1996).
To determine whether BDM inhibited viral endocytosis,
we compared the effects of BDM and chloroquine, a
lypophilic amine that blocks nucleocapsid release from
the endosome (Charlton and Volkman, 1993). Infection
becomes progressively less sensitive to chloroquine dur-
ing the first hpi, and treatment with chloroquine from 1 to
6 hpi (i.e. there was no drug from 0 to 1 hpi) had little
effect on LacZ signaling (Fig. 7B), indicating that after
one hour, most of the viral nucleocapsids had been
released from endosomes and entered the cytoplasm. In
contrast, treatment with BDM from 1 to 6 hpi significantly
decreased the number of LacZ- expressing cells (Fig.
7B), suggesting that BDM affected a post-endocytotic
component of the infection pathway. Furthermore, treat-
ment of cells with CD or with the actin depolymerizing
agent latrunculin B (Spector et al., 1989; Asycough et al.,
1997), but not with the microtubule depolymerizing agent
colchicine, resulted in similar reduction in LacZ signaling
FIG. 6. Identification of viral actin-binding proteins. (A) Actin overlay. Samples include: 35 mg of BV (BV); nucleocapsid (NC) and envelopes (ENV)
produced from 35 mg of BV; lysate (100 mg) from untransformed bacteria (control, cntl) or bacteria transformed with a plasmid expressing p78. Samples
were electrophoresed on a 10% SDS-PAGE gel, transferred to nitrocellulose, and blocked as described in Materials and Methods. Blots were overlaid
with blocking buffer containing 10 mg/ml of 125I-labeled G- or F-actin. After a 2 hr incubation, filters were rinsed and exposed on a PhosphorImager.
(B) Western blot of BV using antiserum to p39 or p78/83. (C) Competition with un-labeled actin: BV (35 mg) was processed for actin overlay as in (A).
After blocking, blots were overlaid with fresh blocking buffer alone (2) or with blocking buffer containing 1 mg/ml (100 fold excess) of un-labeled G3F
or F-actin (1). The overlay solution was then removed, mixed with 10 mg/ml of 125I-labeled G- or F-actin, re-overlaid on the filter, and incubated for
an additional 2 hours after which filters were rinsed and exposed on a PhosphorImager. Positions of pre-stained molecular weight markers and of
p78 and p39 are indicated.
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10(data not shown), supporting the conclusion that actin
and myosin are involved in nucleocapsid transport to the
nucleus. BDM treatment did not interfere with progeny
virus production after nucleocapsid transport to the nu-
cleus, however, suggesting that nuclear transport per se
(of viral encoded proteins, for example), was not inhibited
(data not shown). Direct visualization of nucleocapsids in
untreated, infected cells revealed that at 5 hpi nucleo-
capsids were visible as discrete particles, many of which
appeared to have entered the nucleus (Fig. 8A). In the
presence of BDM, however, the nucleocapsids appeared
to aggregate in the cytoplasm (Fig. 8B). Control experi-
ments performed with secondary antibody alone con-
firmed the specificity of staining (data not shown). To-
gether, these data suggested that actin and a myosin-
like protein may be involved in transport of the
nucleocapsid to the nucleus and/or through the nuclear
pore, a possibility that is also compatible with our data
(Schindler and Jiang, 1986; Berrios et al., 1991).
DISCUSSION
Experiments presented herein demonstrated that Ac-
MNPV BV nucleocapsids were able to bind actin tightly
and nucleate actin polymerization in vitro, findings which
confirmed and extended the previous observation that
AcMNPV nucleocapsids induce the formation of actin
cables shortly after entry into the host cell cytoplasm
(Charlton and Volkman, 1993). Together these findings
provide the first example of direct induction of actin
polymerization in vivo and in vitro by a virus.
Actin nucleation is the stabilization of actin monomers
into trimers which can then elongate into filaments (Weg-
ner and Engel, 1975). The actin nucleating activity of the
nucleocapsid fraction could not be attributed directly to
its associated actin, as the envelope fraction contained
more actin than the nucleocapsid fraction but was un-
able to nucleate actin polymerization. It is possible that
the nucleocapsid-associated actin, bound to either p39
or p78/83, acted as nuclei or ’seeds’ for actin polymer-
ization. Such a model implies that the nucleocapsid-
associated actin is physically different than actin in the
envelope fraction and would be consistent with the re-
sults of the sBV-actin polymerization experiments 1/2
CD if the nucleocapsid-associated actin seeds were
capped at the pointed ends by nucleocapsids. The ob-
servation that nucleocapsids are able to induce the po-
lymerization of actin in vivo (Charlton and Volkman, 1993),
while microinjected actin seeds are not (Sanders and
Wang, 1990), suggests the actin-nucleating activity asso-
ciated with nucleocapsids is fundamentally different
from that of traditional actin seeds.
Interpretation of the in vitro polymerization data, how-
ever, is complicated by the presence of two actin-binding
proteins, p39 and p78/83, in nucleocapsids. It is possi-
ble, for example, that one of these proteins nucleated
actin polymerization, not necessarily from the pointed
end, and that the other protein bound and capped the
pointed end of the nascent filaments. It is unlikely that
the pointed-end actin-binding activity is due to the pres-
ence of host protein tropomodulin, known to bind the
pointed end of actin filaments (Weber et al., 1994), as
tropomodulin antiserum failed to react in western blots of
FIG. 7. BDM delays viral protein expression. Cells were infected with AcMNPV-hsp70/lacZ, a recombinant virus that expresses LacZ under the
control of the Drosophila hsp70 promoter. Infections were made as synchronous as possible (see Materials and Methods) such that the earliest
possible viral entry into the cytoplasm was at 0 hpi. (A) Cells were infected and treated with BDM beginning at 0 hpi (1BDM). Controls received
medium without BDM (2BDM). At the indicated hpi, cells were fixed, and the number of LacZ positive cells determined. (B) Cells were infected and
treated with medium without drug from 0 to 1 hpi. At 1 hpi, the medium was replaced with fresh medium with or without 20 mM BDM and/or 1 mM
chloroquine (CQ), and the infection was allowed to continue until 6 hpi, at which time the cells were fixed and the number of LacZ signaling cells
was determined. All values are the average of 4-6 wells. Error bars, 1 standard deviation.
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BV while it specifically recognized a protein in blots of
extracts of Trichoplusia ni larval muscle tissue (data not
shown). Precise understanding of the independent roles
of p39 and p78/83 in actin polymerization in vitro and in
vivo will require purifying these proteins and testing their
actin-binding properties separately. Preliminary studies
of bacterial expressed p78, however, indicated that al-
though p78 bound actin in overlay assays, it was unable
to nucleate polymerization of pyrene-labeled actin (data
not shown). Whether this lack of nucleating activity is an
accurate characterization of authentic p78 or an artifact
of its having been expressed in bacteria remains to be
determined. Actin-nucleating experiments conducted
with purified p39, on the other hand, have been intracta-
ble because of the tendency of this protein to form
insoluble aggregates. While it will be important to finally
characterize the actin-binding activities of purified p39
and p78, it is significant that the biologically relevant
infecting ’units’, the nucleocapsids, can induce actin po-
lymerization in vitro.
Although the binding of nucleocapsids to the
pointed end of actin filaments needs to be confirmed
by a CD-independent method, such an orientation
would be useful for a barbed-end directed myosin-type
motor to move nucleocapsids along the filaments to-
ward the nucleus, or, alternatively, for nucleocapsids
attached to the pointed end of actin filaments to be
pushed toward the nucleus by myosin in a mechanism
similar to retrograde flow (see Welch et al., 1997).
Several experimental results suggest that the cables
could be used for nucleocapsid transport through the
cytoplasm early in infection. First, the number of ca-
bles formed is directly correlated with the number of
infecting virus particles (Charlton and Volkman, 1993).
Second, nucleocapsids are frequently seen associ-
ated with the ends of actin cables soon after their
release from the endosomes, suggesting that cables
may form in association with and extend away from
nucleocapsids. Third, the cables often appear to ex-
tend toward the nuclei (Charlton and Volkman, 1993).
Finally, the timing of early viral gene expression in the
nuclei is delayed by treatment with BDM, a drug know
to inhibit the myosin ATPase. While BDM also has
been reported to block calcium channels (Allen and
Chapman, 1995), and calcium levels have been re-
ported to affect induction of immediate early genes in
response to extracellular signals (Roche and Prentki,
1994), our data suggest that BDM acts after viral at-
tachment and endocytosis, the period during which
viral induction of transmembrane signaling would oc-
cur. It is therefore most likely that treatment of infected
cells with BDM inhibited an actin-based, myosin-like
motor, thereby delaying nucleocapsid movement to-
ward and/or entry into the nucleus.
MATERIALS AND METHODS
Cell culture and virus purification
Spodoptera frugiperda Sf9 cells (ATCC CRL 1711) were
infected at a multiplicity of infection (moi) of 3 with third
passage AcMNPV, strain E2, (Smith and Summers, 1978)
and incubated for 48 hours according to Lanier et al.
(1996). The medium was cleared of cells and BV was
pelleted through a 25% sucrose cushion by centrifuga-
tion for 45 minutes at 100,000g. The virus pellet was
resuspended in 10 mM Tris, pH 8.5, and an aliquot
removed for protein analysis using the BCA reagent
(Pierce, Rockford, IL). Glycerol was added to the remain-
der (final concentration, 50%), and the stock virus was
stored at 220°C in a non-defrosting freezer. Before use,
the virus was diluted 1:2 in 10 mM Tris, pH 8.5, pelleted
at 80,000g for 30 minutes and resuspended in 10 mM
Tris, pH 8.5.
Virus fractionation and analysis
Viral fractions were obtained as follows: 100 mg ali-
quots of BV were solubilized with 1% NP40 (Fig. 2A) to
make solubilized budded virus (sBV). sBV was centri-
fuged at 80,000g for 30 minutes to obtain the nucleocap-
sid (pellet) and envelope (supernatant) fractions. Nucleo-
capsids were resuspended in 10 mM Tris, pH 8.5, prior to
use. Alternatively, capsids were prepared by incubating
nucleocapsids in 100 ml of nucleocapsid lysis buffer (10
mM Tris, pH 8.5, 2 mM ATP, 1 M NaCl, 2.5 mM MgCl2) for
1 hour at 37° followed by addition of four volumes of
DNAse buffer (10 mM Tris, pH 8.5, 1.25 mM MgCl2, 1
mg/ml pancreatic DNAse I). After another hour of incu-
bation at 37°C (or until the solution was no longer vis-
cous), capsids were pelleted in a Beckman airfuge at 22
psi and resuspended in 10 mM Tris, pH 8.5. The digested
DNA and p6.9, the DNA packaging protein (DNA CORE),
remained in the supernatant fraction. The viral fractions
were analyzed by western blot (Sambrook et al., 1989).
After transfer, the membrane was incubated for 1 hour in
blocking buffer [(2.3% (w/v) non-fat dried milk, 0.5% (w/v)
BSA, 0.1% (v/v) Tween-20, 0.5% (v/v) NP-40) in TBS]. Pri-
mary and secondary antibodies were diluted in blocking
buffer and incubated with the blot for 1 hour each with a
30 minute rinse in between with TBS containing 0.3%
Tween-20 (TBS-T). Monoclonal antibodies to p39 (the
major capsid protein) and gp64 (the major envelope
glycoprotein), and antiserum to p78/83 (a minor capsid
protein) were used to verify fractionation and/or solubi-
lization (Whitt and Manning, 1988; Keddie et al., 1989;
Vialard and Richardson, 1993). Actin and tropomodulin
were identified using the C4 monoclonal antibody (Les-
sard, 1988) and tropomodulin antiserum (Fowler, 1990).
respectively . Goat anti-rabbit or goat anti-mouse horse-
radish peroxidase-conjugated secondary antibodies
(Sigma, St. Louis, MO) were used in conjunction with the
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ECL chemiluminescence reagent (Amersham, Arlington
Heights, IL) or with 3, 39-diaminobenzidine (DAB; Sigma,
St. Louis, MO). Coomassie staining of an un-transferred
gel was used to verify the presence of p6.9 (Wilson et al.,
1987).
Actin purification
Actin, purified from rabbit muscle as described
(Pardee and Spudich, 1982), was aliquoted and stored at
280°C as G-actin in a modified buffer A (10 mM Tris pH
8.5, 0.2 mM CaCl2, 0.2 ATP, 0.2 mM DTT). The concen-
tration of G-actin was determined by absorbance at 290
nm (extinction coefficient 26,600 cm21M21, Mr 42 kDa).
Typical preparations from 0.5 kg of muscle yielded 15-20
ml of G-actin at 3-4 mg/ml.
Visualization of polymerization
Glass coverslips, soaked overnight in 1% HCl/70%
ethanol and rinsed extensively with distilled water, were
sterilized by baking overnight at 75°C. A 50 ml drop of
0.1% (w/v) poly-L-lysine (Sigma, St. Louis, MO) in distilled
H20 was spread on each coverslip and air dried. Virus
samples were mixed with 1 mM G-actin (unlabeled), then
203 initiation mix was added to induce polymerization
by forming F buffer (final concentration 10 mM Tris, pH
8.5, 0.5 mM ATP, 2.0 mM MgCl2) and spread onto a
coverslip. Coverslips were incubated in the dark for 30
minutes then the liquid was aspirated off, and 0.5 ml of F
buffer was overlaid for 1 minute, then removed by aspi-
ration. F-actin was labeled by incubation with 100 ml of
1.5 mM rhodamine-phalloidin (Sigma, St. Louis, MO) in F
buffer for 1 hour in the dark, then the liquid was removed
and the coverslips rinsed for 5 minutes in PBS. The
samples were then incubated with 4 mg/ml 49,6-dia-
midino-2-phenylindole, dihydrochloride (DAPI; Sigma, St.
Louis, MO) in PBS for 1 minute, rinsed for 2 minutes in
PBS and mounted with non-bleach mountant (1 mg/ml
p-phenylenediamine in 0.13 PBS, 90% glycerol).
Preparation of pyrene-labeled actin
Pyrene-labeled actin was prepared essentially as de-
scribed (Kouyama and Mihashi, 1981). An aliquot of G-
actin (25 mg) was thawed overnight at 4°C and clarified
by centrifugation for 1 hour at 80,000g followed by addi-
tion of 2 mM MgCl2 and 100 mM KCl to induce polymer-
ization. The mixture was incubated at 4°C overnight then
centrifuged for 1.5 hour at 80,000g. The pellet was resus-
pended in 10 ml of buffer P (10 mM Hepes, pH 7.4, 2 mM
MgCl2, 100 mM KCl, 0.5 mM ATP), gently vortexed as
1.4 g N-(1-pyrenyl) iodoacetamide (Molecular Probes,
Eugene, OR) dissolved in 100 ml of dimethylsulfoxide was
added, incubated at 4°C for at least 16 hours to allowing
coupling, then dialyzed for 72 hours against 3 changes of
modified buffer A, all in the dark. Finally, the preparation
was clarified by centrifugation as above, and aliquots of
pyrene-labeled G-actin were stored at 280°C in modi-
fied buffer A.
Actin polymerization studies
Pyrene is a fluorescent molecule that is covalently
attached to the carboxy terminus of the actin monomer
via the penultimate amino acid residue (a cysteine). As
the pyrene-labeled actin polymerizes, the pyrene emis-
sion peak at 407 nm intensifies 20-25 fold (Kouyama and
Mihashi, 1981). For all polymerization studies, unlabeled
and pyrene-labeled G-actin were thawed overnight at
4°C, clarified by centrifugation for 1-2 hours at 80,000g,
diluted to 20 mM in G buffer (10 mM Tris pH 8.5, 0.2 mM
CaCl2, 0.2 mM ATP, 0.2 mM DTT) and mixed to give
approximately 80% unlabeled and 20% pyrene-labeled
actin (concentrations determined by optical density). As-
says were conducted in a fluorescence cuvette; actin
and virus were mixed and polymerization was induced
by adding 203 initiation mix to form F buffer (final vol-
ume, 100 ml). For studies with cytochalasin D (CD), 0.5
mM CD (Sigma, St. Louis, MO) was added to the virus
and actin just before addition of the initiation mix. Unless
otherwise indicated, all pyrene-actin studies were done
using 5 mM actin and viral fractions produced from 100
mg of BV (approximately 1 3 1011 virus particles; Volkman
et al., 1976). Fluorescence recording was begun imme-
diately after initiation of polymerization, and readings
were taken continuously with a Hitachi F-4010 fluorom-
eter (Hitachi Instruments, Mountain View, CA) at an ex-
citation wavelength of 365 nm, an emission wavelength
of 407 nm and bandpasses of 10 nm. A neutral density
filter was used to reduce bleaching.
Actin iodination
Iodination was carried out with the IODOBEAD re-
agent (Pierce, Rockford, IL) as described previously
(Lanier et al., 1996). An aliquot of 125I-actin was tested to
insure that the actin was able to polymerize and depo-
lymerize. Iodinated G-actin was clarified at 80,000g for 2
hours before use in the overlay.
Actin overlays
Actin overlays were performed essentially as de-
scribed (Chia et al., 1991). A pT7-7 expression vector that
contained AcMNPV ORF8 was used to express p78 in
BL21 bacteria as described (Vialard and Richardson,
1993). Samples were electrophoresed on a 10% SDS-
PAGE gel and transferred to nitrocellulose for 16 hours at
4°C at a constant 20 volts in a 5 liter blotting tank.
Transferred proteins were fixed by incubation for 1 hour
at 50°C in PBS, then blocked by incubating for at least 2
hours in overlay block (5% w/v non-fat milk powder in
TBS-T). For overlay with F- actin, iodinated G-actin was
diluted to 1 mg/ml (24 mM) in the presence of 0.24 mM
gelsolin (a gift from P. Janmey) and polymerized on ice for
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10 minutes by addition of 0.5 mM ATP, 0.2 mM CaCl2, 2
mM MgCl2 and 100 mM KCl. This produces gelsolin-
capped filaments. To further stabilize the filaments, 40
mM phalloidin was added and polymerization was con-
tinued for 20 minutes at room temperature after which
the actin was diluted to 10 mg/ml in overlay block. G-actin
was diluted directly to 10 mg/ml in overlay block. For
competition studies, blots were overlaid with 1 mg/ml
unlabeled G- or F-actin in overlay block (prepared in the
same manner as labeled actin). G-actin at 1 mg/ml will
polymerize in overlay block, therefore this is designated
G3F competition. After 2 hours, the unlabeled actin was
removed, mixed with 10 mg/ml 125I-actin, re-overlaid on
the blot and incubated for an additional 2 hours. Blots
were then rinsed 5 times with TBS-T for 2 minutes each,
air dried and exposed on a PhosphorImager.
BDM studies
AcMNPV-hsp70/lacZ, a recombinant baculovirus con-
taining the b-galactosidase (LacZ) reporter gene driven
by the Drosophila hsp70 promoter (Engelhard et al.,
1994), was used for these studies. The hsp70 promoter
functions as an immediate early viral promoter, thus LacZ
is expressed immediately upon uncoating in the nucleus.
For all studies, 3 3 104 log phase Sf21 cells were plated
in each 5 mm well of a 12-well, acid-washed slide. After
45 minutes at 27°C, the slides were transferred to 4°C
for 15 minutes then the medium was replaced with 15 ml
of chilled (4°C) medium containing viral inoculum (moi of
0.01). Virus adsorption, but not endocytosis, was
achieved by incubating the slides for 1 hour at 4°C.
Following adsorption, residual inoculum was replaced
with 27°C medium (allowing endocytosis to begin) with
or without 20 mM 2,3, butanedione monoxime (BDM)
and/or 1 mM chloroquine (Sigma, St. Louis, MO). When
chloroquine was used, the medium was adjusted to pH
7.0. Latrunculin B (5 mM; LC Laboratories, Woburn, MA),
CD (10 mM) and colchicine (100 mM; Sigma, St. Louis,
MO) were also tested. The medium was removed at the
indicated times, and the cells were fixed and processed
for LacZ as described (Volkman and Goldsmith, 1982;
Engelhard et al., 1994). When wells contained more than
500 LacZ positive cells, the values were designated
‘‘greater than 500’’; otherwise, all positive cells were
counted and the means calculated for each time point.
Immunofluorescence microscopy
Individual acid-washed glass coverslips (22 mm2)
were placed in wells of a 6-well tissue culture dish, and
5 3 105 Sf21 cells in 0.25 ml of medium were pipetted on
each coverslip and incubated for 1 hour. Infections (syn-
chronized and treated with BDM as described above)
were initiated with AcMNPV-hsp70/lacZ (moi of 100).
After 5 hours at 27°C, coverslips were rinsed with cold
PBS and fixed for 15 minutes in 3.7% formaldehyde in
PBS. Cells were then rinsed with PBS, solubilized by
incubation for 15 minutes in 0.15% NP40 in PBS, then
blocked by incubation for 15 minutes with 1% normal
goat serum in PBS. Coverslips were inverted on a 50 ml
drop of antibody to p39 diluted 1:200 in PBS and incu-
bated for 1 hour, then rinsed for 5 minutes in PBS,
inverted on a 50 ml drop of a 1:400 dilution of goat
anti-mouse antibody conjugated to fluorescein, and in-
cubated for an additional hour. Finally, coverslips were
rinsed for 5 minutes in PBS, stained with 0.5 mg/ml DAPI
for 30 seconds, rinsed again, then mounted with non-
bleach mountant. Images were captured directly onto
slide film using a Zeiss Axiophot photomicroscope
equipped for fluorescence microscopy. The slides were
then scanned and a composite image made using Adobe
Photoshop.
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